Joseph Truitt Insider Trading
Get free email notifications about insider trading for Joseph Truitt.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Joseph Truitt. Joseph Truitt is an Chief Executive Officer in BIOSPECIFICS TECHNOLOGIES CORP ($BSTCE) and a Chief Commercial Officer in ACHILLION PHARMACEUTICALS INC ($ACHN) and an Chief Executive Officer in ACHILLION PHARMACEUTICALS INC ($ACHN) and a EVP, Chief Commercial Officer in ACHILLION PHARMACEUTICALS INC ($ACHN) and a SVP, Chief Commercial Officer in ACHILLION PHARMACEUTICALS INC ($ACHN) and a VP, Chief Commercial Officer in ACHILLION PHARMACEUTICALS INC ($ACHN) and a Director in Larimar Therapeutics, Inc. ($ZFGN).
Address: C/O ACHILLION PHARMACEUTICALS 300 GEORGE STREET NEW HAVEN 06511 CT
Companies in which Joseph Truitt is an Insider
ACHILLION PHARMACEUTICALS INC
Trading Symbol: ACHNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Joseph Truitt: Chief Executive Officer, EVP, Chief Commercial Officer, SVP, Chief Commercial Officer, VP, Chief Commercial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 29 2020
$ACHN Market Capitalization: $579.52M
$ACHN Previous Close: $4.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIOSPECIFICS TECHNOLOGIES CORP
Trading Symbol: BSTCEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Joseph Truitt: Chief Executive Officer
Holdings: 0 shares
Latest Transaction: May 29 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Larimar Therapeutics, Inc.
Trading Symbol: LRMRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Joseph Truitt: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 30 2020
$LRMR Market Capitalization: $109.05M
$LRMR Previous Close: $4.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Joseph Truitt
Sentiment: All, ACHN, BSTCE, LRMR
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 30 2020 | ZFGN | Larimar Therapeuti ... | Truitt Joseph | Director | Option Exercise | A | 11.90 | 16,600 | 197,540 | 16,600 | |
May 29 2020 | BSTCE | BIOSPECIFICS TECHN ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | A | 63.72 | 130,000 | 8,283,600 | 130,000 | |
Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 2.18 | 1,097,000 | 2,391,460 | 0 | |
Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 2.90 | 419,000 | 1,215,100 | 0 | |
Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 3.02 | 200,000 | 604,000 | 0 | |
Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 3.10 | 87,766 | 272,075 | 0 | |
Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 3.66 | 30,000 | 109,800 | 0 |